BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33946048)

  • 1. PDGFR-β
    Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
    Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors.
    Hu G; Wang S; Xu F; Ding Q; Chen W; Zhong K; Huang L; Xu Q
    Cell Physiol Biochem; 2018; 51(3):1041-1050. PubMed ID: 30476924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients.
    Hu G; Xu F; Zhong K; Wang S; Huang L; Chen W
    J Cancer; 2018; 9(20):3736-3742. PubMed ID: 30405845
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
    Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
    PeerJ; 2024; 12():e16958. PubMed ID: 38410801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.
    Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
    J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal PDGFR-β Expression is Associated with Postoperative Survival of Non-Small Cell Lung Cancer Patients Receiving Preoperative Chemo- or Chemoradiotherapy Followed by Surgery.
    Kanzaki R; Ose N; Kawamura T; Funaki S; Shintani Y; Minami M; Takakura N; Okumura M
    World J Surg; 2018 Sep; 42(9):2879-2886. PubMed ID: 29511870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
    Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating CD45RO
    Hu G; Wang S
    Sci Rep; 2017 Sep; 7(1):10376. PubMed ID: 28871164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients.
    Akanda MR; Ahn EJ; Kim YJ; Salam SMA; Noh MG; Lee TK; Kim SS; Lee KH; Moon KS
    BMC Cancer; 2023 May; 23(1):468. PubMed ID: 37217880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAG-3
    Hu G; Wang S; Wang S; Ding Q; Huang L
    Front Oncol; 2022; 12():986903. PubMed ID: 36761428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating tryptase
    Hu G; Wang S; Cheng P
    Int J Cancer; 2018 Feb; 142(4):813-821. PubMed ID: 29023696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
    Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
    Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
    Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
    Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFR-beta expression in small cell lung cancer patients.
    Shinohara ET; Gonzalez A; Massion PP; Olson SJ; Albert JM; Shyr Y; Carbone DP; Johnson DH; Hallahan DE; Lu B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):431-7. PubMed ID: 17236966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis.
    Wang S; Li Z; Hu G
    Oncotarget; 2017 Sep; 8(39):66382-66391. PubMed ID: 29029520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
    Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
    J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of tumor-infiltrating CD57-positive lymphocytes in solid tumors: a meta-analysis.
    Hu G; Wang S
    Oncotarget; 2018 Jan; 9(8):8111-8119. PubMed ID: 29487719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myeloma.
    Bilalis A; Pouliou E; Roussou M; Papanikolaou A; Tassidou A; Economopoulos T; Terpos E
    J BUON; 2017; 22(4):1032-1037. PubMed ID: 28952224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
    Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
    Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.
    Frödin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandström P; Egevad L; Johansson M; Östman A
    Br J Cancer; 2017 Jan; 116(2):195-201. PubMed ID: 27931046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.